Panacea Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PANACEA, and what generic and branded alternatives to PANACEA drugs are available?
PANACEA has three approved drugs.
Summary for Panacea
US Patents: | 0 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
PTAB Cases with Panacea as petitioner: | See PTAB cases with Panacea as petitioner |
Drugs and US Patents for Panacea
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panacea | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897-001 | Oct 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-002 | Sep 28, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-003 | Sep 28, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Panacea | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 204722-001 | Jan 11, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Panacea | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897-002 | Oct 16, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.